deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00851877

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

A Phase I/II Study of Nab-paclitaxel, Cisplatin and Cetuximab With Concurrent Radiation Therapy for Local-regionally Advanced Head-and-neck Squamous Cell Carcinoma

Sponsor: University of Texas Southwestern Medical Center

Conditions Head and Neck Cancer
Interventions Cetuximab Cisplatin Nab-Paclitaxel intensity-modulated radiation therapy
Updated 10 times since 2017 Last updated: Aug 19, 2020 Started: Mar 1, 2009 Primary completion: Oct 1, 2013 Completion: Aug 3, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Head and Neck Cancer and is currently completed. University of Texas Southwestern Medical Center leads this study, which shows 10 recorded versions since 2009 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotActive Not Recruiting~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshotUnknown Status~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotCompleted~Sep 2018 – ~Sep 2020 · 24 months · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Sep 2018 — Sep 2020 [monthly]

    Completed PHASE1_PHASE2

▶ Show 5 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Completed PHASE1_PHASE2

  2. Dec 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    Status: Unknown Status → Completed

  3. Jun 2017 — Dec 2017 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Active Not Recruiting → Unknown Status

  4. Feb 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Texas Southwestern Medical Center
Data source: University of Texas Southwestern Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations